DataMeds AI MEDS
NASDAQ MEDS
$0.85 -0.02 (-2.31%)
At close: Sep 9, 2026 · 4:00 PM EDT

DataMeds AI (MEDS) Price to Sales (2025 - 2026)

DataMeds AI's (MEDS) quarterly Price to Sales came in at 7.35 in Q1 2026, down 69.93% on a YoY basis from 24.44 in Q1 2025, and down 56.76% quarter-over-quarter from 17.0 in Q4 2025.

Analysis

DataMeds AI (MEDS) Price to Sales (2025 - 2026) Analysis & Trends

DataMeds AI (MEDS) has reported Price to Sales for 2 consecutive years, with 7.35 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Price to Sales fell 69.93% year-over-year to 7.35; the trailing twelve-month figure through Mar 2026 stood at 0.82 (down 91.08% YoY), and the FY2025 full-year result was 1.22, changed N/A from the prior year.
  • Price to Sales slipped to 7.35 in Q1 2026 per MEDS's latest filing, from 17.0 in the prior quarter.
  • Across five years, Price to Sales topped out at 24.44 in Q1 2025 and bottomed at 7.35 in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Mckesson 106.22 Bn 101.06 Bn 3.69 Bn
2 Cencora 62.63 Bn 59.81 Bn 3.61 Bn
3 Cardinal Health 56.55 Bn 51.69 Bn 2.56 Bn
4 Henry Schein 9.98 Bn 9.82 Bn 1.10 Bn
5 ZeroStack 42.33 Mn 39.37 Mn 1.62 Mn
6 111 27.24 Mn -27.13 Mn 18.18 Mn
7 Guardian Pharmacy Services 5.51 Mn -84.30 Mn 80.04 Mn
8 Ridgetech 4.71 Mn -13.30 Mn -
9 MedWellAI 2.27 Mn 2.28 Mn -
10 DataMeds AI 1.78 Mn 1.73 Mn 170,221.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7.35
Dec 31, 2025 17.00
Sep 30, 2025 21.90
Jun 30, 2025 7.85
Mar 31, 2025 24.44